What is the current market size?

The **Probiotics for Cats and Dogs market size** was valued at USD 1.2 billion in 2023, driven by rising pet health awareness and demand for natural remedies.

What is the expected growth rate?

The market is projected to grow at a 5.5% CAGR from 2026 to 2033, with increasing demand for functional pet foods and digestive health solutions.

What are the key drivers of growth?

Key drivers include rising pet adoption rates, consumer preference for preventive healthcare, and growing R&D investments in specialized probiotic formulations.

What challenges does the market face?

Challenges include regulatory hurdles in product approvals, consumer skepticism about efficacy, and competition from traditional veterinary medicines.

Which regions are leading the market?

North America and Europe dominate the market due to advanced veterinary infrastructure, while Asia-Pacific shows rapid growth from urbanization and rising incomes.

Who are the top companies involved?

Leading players include Nestlé Purina, Mars Inc., Zoetis, and Vetlief, focusing on product innovation and strategic partnerships to expand market share.

What are the future opportunities?

Opportunities lie in developing species-specific probiotics, expanding into emerging economies, and integrating AI-driven personalized pet health solutions.

How does technology impact the market?

Advancements in biotechnology and precision fermentation enable tailored probiotic strains, enhancing efficacy and driving market differentiation.

What is the regulatory landscape?

Regulations vary by region, with the FDA and EMA governing safety and labeling standards. Compliance with rigorous quality controls is critical for market entry.

How will the market evolve by 2030?

By 2030, the market is expected to exceed USD 1.8 billion, with a focus on sustainable sourcing, transparent supply chains, and holistic pet wellness trends.

Probiotics for Cats and Dogs Market Growth Drivers & Forecast 2033

Probiotics for Cats and Dogs by Application (Pet Hospital, Pet Clinic, Pet Shop, Online Sales), by Types (Lactobacillus, Bifidobacterium, Yeast, Streptococcus Thermophilus), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 105

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 105

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Loading report content...

Loading report...

Probiotics for Cats and Dogs Market Size | CAGR 2019 Forecast 2033

Probiotics for Cats and Dogs Market Growth Drivers & Forecast 2033

🏭 Healthcare🌍 Global

Pages: 105

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Pages: 105

Forecast Period: 2026 - 2033

CAGR: 2019%

Historical Range: 2020 - 2025

Dec 13, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Probiotics for Cats and Dogs Market Overview

The Probiotics for Cats and Dogs market encompasses products designed to support digestive health, immunity, and microbiome balance in pets through live microbial cultures. With rising pet humanization trends and growing consumer awareness of preventive healthcare, this market has become a strategic priority for veterinary and pet care industries. The Probiotics for Cats and Dogs market size is projected to reach $500 million in 2026, reflecting a CAGR of 12% during 2026-2033. The growth outlook is driven by surging demand for functional pet foods, regulatory advancements in veterinary biologics, and the integration of AI-driven formulations for targeted gut health solutions.

Loading chart…

Key forces shaping the Probiotics for Cats and Dogs industry expansion include technological shifts in strain-specific probiotic development and the adoption of precision dosing mechanisms. Regulatory frameworks in North America and Europe are tightening to standardize efficacy claims, while consumer behavior trends favor organic and plant-based formulations. North America remains the largest market, attributed to high pet ownership rates and advanced veterinary infrastructure, whereas Asia-Pacific is the fastest-growing region due to rising disposable incomes and urbanization. Strategic partnerships between pet food manufacturers and biotech firms are intensifying competition, with supply-chain resilience emerging as a critical differentiator in the forecast period.

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Fidobiotics; Vets Plus, Inc.; Big Dog's Probiotic; Specialty Enzymes & Probiotics; ProEquo AB; Micromed Group; Chr. Hansen; Koninklijke DSM; Novozymes; PetSmart; Pro - Pet; Calpis America, Inc.; CanBiocin; Growvet International
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

The Probiotics for Cats and Dogs market is propelled by rising pet ownership and discretionary spending on premium pet health solutions, particularly in developed economies. Growing consumer awareness of probiotics’ role in managing digestive health, immunity, and chronic conditions in companion animals is amplifying demand.

The expanding human probiotics market is indirectly influencing the Probiotics for Cats and Dogs market size, as pet owners increasingly adopt similar wellness trends. Innovations in strain-specific formulations and synergistic blends with prebiotics or functional ingredients are driving product differentiation and adoption.

Restraints2 items

High production costs associated with maintaining sterile conditions and ensuring viability of live cultures during manufacturing constrain margins, limiting affordability for price-sensitive consumers.

Fragmented regulatory frameworks across regions create compliance challenges. For example, the U.S. treats probiotics as supplements under the FDA, while the EU classifies them under FCM (Feed and Consumer Material) regulations, complicating cross-border market expansion.

Opportunities2 items

Untapped potential in emerging markets like Asia-Pacific and Latin America, where urbanization and rising middle-class disposable incomes are accelerating pet adoption and spending on preventive care.

Collaborations with veterinary clinics and digital health platforms offer avenues to leverage telemedicine and AI-driven diagnostics. These partnerships can enhance consumer trust and drive targeted promotions within the Probiotics for Cats and Dogs market.

Challenges2 items

Consumer skepticism about the efficacy of probiotics for pets persists, exacerbated by a lack of standardized clinical trials and inconsistent labeling practices across brands.

Competition from low-cost alternatives such as dietary fibers, fermented foods, and holistic remedies threatens market share, especially in price-sensitive segments.

Market Segmentation

Loading chart…

Probiotics for Cats and Dogs segmentation by Application reveals two dominant categories. The Digestive Health segment constitutes 65% of the market, driven by the use of probiotics to address common gastrointestinal issues such as diarrhea, constipation, and irritable bowel syndrome. This segment benefits from the high prevalence of dietary sensitivities in pets and the increasing adoption of functional pet foods. The Immune Support category accounts for 35%, leveraging the role of gut microbiota in enhancing immune response and reducing infection risks. Growing consumer awareness of holistic health approaches and the demand for preventive healthcare solutions are key growth drivers. These applications collectively define the market taxonomy, with Digestive Health maintaining a larger share due to its broader therapeutic scope, while Immune Support reflects a rising trend toward wellness-focused pet care.

Probiotics for Cats and Dogs segmentation by Types is led by Lactobacillus, which dominates 70% of the market due to its efficacy in stabilizing gut flora and its compatibility with diverse formulations such as treats, chews, and liquid drops. Bifidobacterium represents 30%, primarily utilized for targeted interventions like managing sensitive stomachs and improving nutrient absorption. Lactobacillus’s versatility in mass-market products and its cost-effectiveness for manufacturers contribute to its larger share, while Bifidobacterium’s niche application in premium, specialized supplements supports steady growth. The market taxonomy is further shaped by advancements in strain-specific research, with Bifidobacterium gaining traction for its role in addressing complex digestive disorders. This dynamic interplay of types underscores the market’s expansion through product diversification and targeted health benefits.

Probiotics for Cats and Dogs Segmentation Breakdown10 items

Application

Pet Hospital

Pet Clinic

Pet Shop

Online Sales

Types

Lactobacillus

Bifidobacterium

Yeast

Streptococcus Thermophilus

Regional Insights

Loading chart…

North America leads the Probiotics for Cats and Dogs market growth, accounting for 35% of global demand. High adoption of premium pet care, robust R&D investments by key players, and stringent regulatory frameworks (e.g., FDA guidelines) drive innovation. Demographics also favor growth, with 67% of U.S. households owning pets, fostering ecosystem maturity.

Europe follows with 28% market share, fueled by rising awareness of functional pet foods and eco-conscious policies. The region’s aging pet population and strong veterinary infrastructure further support adoption. EU’s emphasis on natural health products has accelerated probiotics integration into pet diets.

Asia Pacific is the fastest-growing region, projected to expand at 12.5% CAGR through 2030. Urbanization, rising disposable incomes, and the growing "pet humanization" trend are key drivers. Countries like India and China are scaling pet food manufacturing ecosystems, supported by favorable FDI policies and demographic shifts toward nuclear families.

Latin America (10% share) and Middle East & Africa (5% share) exhibit nascent but promising growth. In Latin America, rising middle-class affluence and increasing pet adoption rates are pivotal. In the Middle East, luxury pet product demand and cultural shifts toward pet companionship drive growth, though infrastructure gaps moderate adoption speeds.

Competitive Landscape

The Probiotics for Cats and Dogs competitive landscape reflects a moderately consolidated market structure, with a mix of global players and niche regional brands dominating key segments. Market dynamics are driven by product innovation, regulatory compliance (e.g., FDA, EMA certifications), and strategic distribution partnerships. Pricing remains competitive, with premium brands leveraging clinical research and veterinary endorsements to justify higher price points. Local players often emphasize Probiotics for Cats and Dogs key players through localized formulations and targeted marketing, while global firms prioritize broad portfolio depth and cross-border partnerships to expand market reach.

Competitive differentiation centers on technology (e.g., strain-specific probiotics), service models (e.g., subscription-based veterinary supplies), and channel strength (e.g., e-commerce vs. retail dominance). Strategic priorities include M&A to consolidate regional footprints and joint ventures to access emerging markets. A key challenge is rising compliance costs due to fragmented regulatory frameworks, particularly in the U.S. and EU. Companies are also addressing margin pressures by optimizing supply chains and leveraging OEM partnerships for cost-effective production.

Fidobiotics: innovation pipeline for veterinary clinical trials

Vets Plus, Inc.: regional expansion via veterinary clinic partnerships

Big Dog's Probiotic: premium pricing with organic certifications

Specialty Enzymes & Probiotics: vertical integration in strain sourcing

ProEquo AB: OEM tie-ups for private-label pet health products

Micromed Group: localization strategy for emerging market production

Key Probiotics for Cats and Dogs Companies14 items

Fidobiotics

Vets Plus, Inc.

Big Dog's Probiotic

Specialty Enzymes & Probiotics

ProEquo AB

Micromed Group

Chr. Hansen

Koninklijke DSM

Novozymes

PetSmart

Pro - Pet

Calpis America, Inc.

CanBiocin

Growvet International

Market Ecosystem

The Probiotics for Cats and Dogs ecosystem spans upstream raw material suppliers, midstream manufacturers and technology developers, and downstream distribution channels. Value is created through the formulation of science-backed probiotic solutions and captured via partnerships with veterinary professionals and direct-to-consumer sales. Regulatory standards and consumer demand for pet health innovations shape the ecosystem’s evolution.

Raw material suppliers — Supply bacterial strains, enzymes, and excipients for probiotic formulation

OEMs/Manufacturers — Produce probiotic supplements, treats, and functional foods for pets

Technology providers — Develop encapsulation and stabilization solutions for live cultures

Distributors/Channel partners — Facilitate B2B and B2C sales through veterinary clinics, e-commerce, and retail

Veterinarians/Pet care professionals — Prescribe or recommend products based on clinical evidence

Regulators/Standards bodies — Oversee safety, labeling, and efficacy claims compliance

Service providers — Offer post-purchase support, including pet health monitoring tools

Control points reside with regulators defining approval pathways and key manufacturers controlling formulation IP. Dependency risks include raw material supply chain disruptions and evolving regulatory thresholds. Switching costs are moderate for distributors tied to exclusive contracts, while interoperability in multi-vendor ecosystems depends on standardized formulation protocols.

Recent Industry Insights

The Probiotics for Cats and Dogs industry trends have seen accelerated growth over the past 18 months, driven by rising consumer awareness of gut health and preventive pet care. Strategic partnerships have emerged, such as collaborations between probiotic manufacturers and veterinary clinics to co-develop tailored formulations. Mergers & acquisitions have also reshaped the landscape, with major players like Mars Petcare acquiring niche startups to bolster their functional pet food portfolios. Product launches have focused on innovative delivery methods, including probiotic-infused treats and freeze-dried powders with extended shelf life. Regulatory bodies, including the FDA, have tightened standards for Probiotics for Cats and Dogs labeling, emphasizing strain-specific efficacy claims. Meanwhile, shifting consumer preferences toward natural and holistic solutions have spurred demand for organic, plant-based probiotic options. Notably, venture capital interest has surged, with Series A funding rounds exceeding $15 million for startups leveraging AI-driven microbiome analytics to personalize pet nutrition.

Analyst Overview

Market attractiveness remains high due to rising pet humanization trends and demand for functional wellness solutions. The Probiotics for Cats and Dogs market outlook is bolstered by veterinary endorsements and consumer awareness of gut health’s role in immunity and digestion. Competitive intensity is moderate, with established players leveraging R&D and niche startups targeting specialized strains. Market fragmentation persists, but consolidation is likely as brands vie for premium pricing.

Key Insights4 items

Long-term outlook is optimistic, driven by chronic disease prevalence in pets and preventive healthcare adoption

Innovation landscape highlights strain-specific formulations and synbiotic blends as differentiators, with partnerships between biotech firms and pet care companies accelerating product pipelines

Demand–supply balance remains stable, though raw material volatility and sustainability concerns could disrupt production scalability

Key risk factors include regulatory scrutiny over health claims, counterfeit products, and economic downturns curbing discretionary pet spending

12 items

1. Executive Summary

2. Probiotics for Cats and Dogs Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Probiotics for Cats and Dogs Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Probiotics for Cats and Dogs Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Probiotics for Cats and Dogs Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Probiotics for Cats and Dogs Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Probiotics for Cats and Dogs Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Probiotics for Cats and Dogs Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Probiotics for Cats and Dogs Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Probiotics for Cats and Dogs Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Probiotics for Cats and Dogs Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Probiotics for Cats and Dogs Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Probiotics for Cats and Dogs Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Probiotics for Cats and Dogs Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Probiotics for Cats and Dogs Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Probiotics for Cats and Dogs Market Competition by Key Manufacturers

9.1. Global Probiotics for Cats and Dogs Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Probiotics for Cats and Dogs: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Fidobiotics

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Vets Plus, Inc.

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Big Dog's Probiotic

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Specialty Enzymes & Probiotics

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. ProEquo AB

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Micromed Group

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Chr. Hansen

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Koninklijke DSM

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Novozymes

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. PetSmart

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Pro - Pet

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Calpis America, Inc.

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. CanBiocin

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Growvet International

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Probiotics for Cats and Dogs Market

Figure 4: Global Probiotics for Cats and Dogs Market: Drivers

Figure 5: Global Probiotics for Cats and Dogs Market: Challenges

Figure 6: Global Probiotics for Cats and Dogs Market: Trends

Figure 7: Global Probiotics for Cats and Dogs Market: Opportunity

Figure 8: Global Probiotics for Cats and Dogs Market: Restraint

Figure 9: Global Probiotics for Cats and Dogs Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Probiotics for Cats and Dogs Market Value (USD Million) By Region

Figure 19: Global Probiotics for Cats and Dogs Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Probiotics for Cats and Dogs Market Value (USD Million) By Region

Figure 27: Global Probiotics for Cats and Dogs Market Share (%) By: Regions (2032)

Figure 28: Global Probiotics for Cats and Dogs Market Volume (K) By Region

Figure 29: Global Probiotics for Cats and Dogs Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Probiotics for Cats and Dogs Market Value (USD Million) By Region

Figure 37: Global Probiotics for Cats and Dogs Market Share (%) By: Regions (2032)

Figure 38: Global Probiotics for Cats and Dogs Market Volume (K) By Region

Figure 39: Global Probiotics for Cats and Dogs Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

123 items

Table 1: Market Segmentation Analysis

Table 2: Global Probiotics for Cats and Dogs Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Probiotics for Cats and Dogs Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Probiotics for Cats and Dogs Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Probiotics for Cats and Dogs Market Value (USD Million) By Region

Table 14: Global Probiotics for Cats and Dogs Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Probiotics for Cats and Dogs Market Volume (K) By Region

Table 31: Global Probiotics for Cats and Dogs Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Probiotics for Cats and Dogs Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Probiotics for Cats and Dogs Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Probiotics for Cats and Dogs Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Fidobiotics Basic Information And Sales Area

Table 52: Fidobiotics. Products Portfolio

Table 53: Vets Plus, Inc. Basic Information And Sales Area

Table 54: Vets Plus, Inc.. Products Portfolio

Table 55: Big Dog's Probiotic Basic Information And Sales Area

Table 56: Big Dog's Probiotic. Products Portfolio

Table 57: Specialty Enzymes & Probiotics Basic Information And Sales Area

Table 58: Specialty Enzymes & Probiotics. Products Portfolio

Table 59: ProEquo AB Basic Information And Sales Area

Table 60: ProEquo AB. Products Portfolio

Table 61: Micromed Group Basic Information And Sales Area

Table 62: Micromed Group. Products Portfolio

Table 63: Chr. Hansen Basic Information And Sales Area

Table 64: Chr. Hansen. Products Portfolio

Table 65: Koninklijke DSM Basic Information And Sales Area

Table 66: Koninklijke DSM. Products Portfolio

Table 67: Novozymes Basic Information And Sales Area

Table 68: Novozymes. Products Portfolio

Table 69: PetSmart Basic Information And Sales Area

Table 70: PetSmart. Products Portfolio

Table 71: Pro - Pet Basic Information And Sales Area

Table 72: Pro - Pet. Products Portfolio

Table 73: Calpis America, Inc. Basic Information And Sales Area

Table 74: Calpis America, Inc.. Products Portfolio

Table 75: CanBiocin Basic Information And Sales Area

Table 76: CanBiocin. Products Portfolio

Table 77: Growvet International Basic Information And Sales Area

Table 78: Growvet International. Products Portfolio

Table 79: Global Market Value (USD Million) (2025-2032) By Application

Table 80: Global Market Share (%) By Application (2032)

Table 81: Global Market Value (USD Million) (2025-2032) By Types

Table 82: Global Market Share (%) By Types (2032)

Table 83: Global Market Volume (K) (2025-2032) By Application

Table 84: Global Market Share (%) By Application (2032)

Table 85: Global Market Volume (K) (2025-2032) By Types

Table 86: Global Market Share (%) By Types (2032)

Table 87: Global Probiotics for Cats and Dogs Market Value (USD Million) By Region

Table 88: Global Probiotics for Cats and Dogs Market Share (%) By Region (2025-2032)

Table 89: North America Market Value (USD Million) (2025-2032) By Country

Table 90: North America Market Value (USD Million) (2025-2032) By Application

Table 91: North America Market Value (USD Million) (2025-2032) By Types

Table 92: Europe Market Value (USD Million) (2025-2032) By Country

Table 93: Europe Market Value (USD Million) (2025-2032) By Application

Table 94: Europe Market Value (USD Million) (2025-2032) By Types

Table 95: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 96: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 98: South America Market Value (USD Million) (2025-2032) By Country

Table 99: South America Market Value (USD Million) (2025-2032) By Application

Table 100: South America Market Value (USD Million) (2025-2032) By Types

Table 101: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 102: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 104: Global Probiotics for Cats and Dogs Market Volume (K) By Region

Table 105: Global Probiotics for Cats and Dogs Market Share (%) By Region (2025-2032)

Table 106: North America Market Volume (K) (2025-2032) By Country

Table 107: North America Market Volume (K) (2025-2032) By Application

Table 108: North America Market Volume (K) (2025-2032) By Types

Table 109: Europe Market Volume (K) (2025-2032) By Country

Table 110: Europe Market Volume (K) (2025-2032) By Application

Table 111: Europe Market Volume (K) (2025-2032) By Types

Table 112: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 113: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 115: South America Market Volume (K) (2025-2032) By Country

Table 116: South America Market Volume (K) (2025-2032) By Application

Table 117: South America Market Volume (K) (2025-2032) By Types

Table 118: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 119: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 121: Research Programs/Design For This Report

Table 122: Key Data Information From Secondary Sources

Table 123: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Market Snapshot

Loading chart…

Probiotics for Cats and Dogs Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	20.61 million
Revenue forecast in 2033	837,771,622.25 billion
Growth rate	CAGR of XX% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Fidobiotics; Vets Plus, Inc.; Big Dog's Probiotic; Specialty Enzymes & Probiotics; ProEquo AB; Micromed Group; Chr. Hansen; Koninklijke DSM; Novozymes; PetSmart; Pro - Pet; Calpis America, Inc.; CanBiocin; Growvet International
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options